April 5, 2016 / 8:27 PM / a year ago

BRIEF-Cipher Pharmaceuticals announces Canadian launch of Beteflam

April 5 (Reuters) - Cipher Pharmaceuticals Inc

* Cipher pharmaceuticals announces canadian launch of beteflam

* Commonly reported adverse drug reactions that occurred in patients using beteflam were skin and subcutaneous tissue disorders

* Expect to continue growth with six products targeted for canadian market in 2016 and eight in 2017 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below